The use of serial circulating tumor DNA (ctDNA) to detect resistance alterations in progressive metastatic breast cancer.
Jacob S, Davis AA, Gerratana L, Velimirovic M, Shah AN, Wehbe F, Katam N, Zhang Q, Flaum L, Siziopikou KP, Platanias LC, Gradishar W, Behdad A, Bardia A, Cristofanilli M. The use of serial circulating tumor DNA (ctDNA) to detect resistance alterations in progressive metastatic breast cancer. Clin Cancer Res. 2020 Dec 15.